France vs Latvia: Proportion of isolates with decreased susceptibility or resistance
France
0
in 2018
Latvia
0
in 2018
France rank
25th
Latvia rank
25th
Proportion of isolates with decreased susceptibility or resistance over time
- France
- Latvia
How they compare
France currently reports 0 against 0 in Latvia, a difference of 0.
The two have swapped places 5 times across 10 shared years of data; in 2009 it was France ahead.
France ranks 25th and Latvia ranks 25th of 51 countries.
France has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | France | Latvia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.92 | 0 | 1.92 | France |
| 2010s | 1.11 | 0.5773 | 0.535 | France |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, France or Latvia?
- France, at 0 against 0 in Latvia as of 2018.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between France and Latvia?
- 0, with France ahead.
- How many years of comparable data are there for France and Latvia?
- 10 years are reported by both, from 2009 to 2018.
- How do France and Latvia rank globally for proportion of isolates with decreased susceptibility or resistance?
- France ranks 25th and Latvia ranks 25th of 51 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to extended-spectrum cephalosporins reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.